MEROXIMER 0.088mg tablets ACTAVIS
pramipexole Indicated for: Parkinson's disease
N04BC05 Nervous system | Dopaminergic agents | Dopamine agonists
letter M · page 22
pramipexole Indicated for: Parkinson's disease
N04BC05 Nervous system | Dopaminergic agents | Dopamine agonists
pramipexole Indicated for: Parkinson's disease
N04BC05 Nervous system | Dopaminergic agents | Dopamine agonists
pramipexole Indicated for: Parkinson's disease
N04BC05 Nervous system | Dopaminergic agents | Dopamine agonists
pramipexole Indicated for: Parkinson's disease
N04BC05 Nervous system | Dopaminergic agents | Dopamine agonists
pramipexole Indicated for: Parkinson's disease
N04BC05 Nervous system | Dopaminergic agents | Dopamine agonists
mesalazine Indicated for: inflammatory bowel disease
mesalazine Indicated for: inflammatory bowel disease
mesalazine Indicated for: inflammatory bowel disease
mesalazine Indicated for: inflammatory bowel disease
mesalazine Indicated for: inflammatory bowel disease
mesalazine Indicated for: inflammatory bowel disease
mesalazine Indicated for: inflammatory bowel disease
mesalazine Indicated for: inflammatory bowel disease
mesalazine Indicated for: inflammatory bowel disease
mesalazine Indicated for: inflammatory bowel disease
mesalazine Indicated for: inflammatory bowel disease
esomeprazole Indicated for: peptic ulcer; gastroesophageal reflux
esomeprazole Indicated for: peptic ulcer; gastroesophageal reflux
pyridostigmine bromide Indicated for: myasthenia gravis
N07AA02 Nervous system | Parasympathomimetics | Anticholinesterases
methadone Indicated for: severe pain; opioid dependence
N07BC02 Nervous system | Drugs used in addictive disorders | Drugs used in opioid dependence